Louis H. Morrone - 06 Dec 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
06 Dec 2021
Net transactions value
-$1,681,388
Form type
4
Filing time
08 Dec 2021, 16:25:44 UTC
Previous filing
06 Jul 2021
Next filing
21 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $482,868 +9,989 +26% $48.34 48,218 06 Dec 2021 Direct
transaction ABT Common shares without par value Sale $1,308,684 -9,989 -21% $131.01 38,229 06 Dec 2021 Direct F1
transaction ABT Common shares without par value Options Exercise $482,820 +9,988 +26% $48.34 48,217 07 Dec 2021 Direct
transaction ABT Common shares without par value Sale $1,338,392 -9,988 -21% $134.00 38,229 07 Dec 2021 Direct
holding ABT Common shares without par value 2,299 06 Dec 2021 Profit Sharing Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -9,989 -33% $0.000000 19,976 06 Dec 2021 Common Shares 9,989 $48.34 Direct F3
transaction ABT Option (right to buy) Options Exercise $0 -9,988 -50% $0.000000 9,988 07 Dec 2021 Common Shares 9,988 $48.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.16, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
F3 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).